Role of the NALP3-inflammasome activation by muramyl dipeptide in vivo

Project Information

NALP3 AND MDP

Grant agreement ID: 25592

Project closed

Start date 1 August 2006

End date 31 July 2008

Funded under

• Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Total cost € 0,00

EU contribution € 183 456,00

Coordinated by

DEPARTEMENT DE BIOCHIMIE, UNIVERSITE DE LAUSANNE
Switzerland

Objective

Innate

Fields of science

• natural sciences › biological sciences › genetics › DNA
• natural sciences › chemical sciences › inorganic chemistry › alkali metals
• medical and health sciences › basic medicine › immunology
• natural sciences › biological sciences › genetics › mutation
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Keywords

• IL
• NALP3
• adjuvant
• immunity
• in vivo

Programme(s)

• FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Topic(s)

• MOBILITY-2.1 - Marie Curie Intra-European Fellowships (EIF)

Call for proposal

FP6-2004-MOBILITY-5
See other projects for this call

Funding Scheme

EIF - Marie Curie actions-Intra-European Fellowships

Coordinator

DEPARTEMENT DE BIOCHIMIE, UNIVERSITE DE LAUSANNE

• EU contribution: No data
• Address: chemin des boveresses 155 ; EPALINGES ; Switzerland
• Total cost: No data